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Abstract
Background: Mercury is an immunotoxic metal that induces autoimmune disease in rodents. Highly
susceptible mouse strains such as SJL/N, A.SW, B10.S (H-2s) develop multiple autoimmune manifestations
after exposure to inorganic mercury, including lymphoproliferation, elevated levels of autoantibodies,
overproduction of IgG and IgE, and circulating immune complexes in kidney and vasculature. A few studies
have examined relationships between mercury exposures and adverse immunological reactions in humans,
but there is little evidence of mercury-associated autoimmunity in humans.
Methods: To test the immunotoxic effects of mercury in humans, we studied communities in Amazonian
Brazil with well-characterized exposures to mercury. Information was collected on diet, mercury
exposures, demographic data, and medical history. Antinuclear and antinucleolar autoantibodies (ANA and
ANoA) were measured by indirect immunofluorescence. Anti-fibrillarin autoantibodies (AFA) were
measured by immunoblotting.
Results: In a gold mining site, there was a high prevalence of ANA and ANoA: 40.8% with detectable
ANoA at ≥1:10 serum dilution, and 54.1% with detectable ANA (of which 15% had also detectable ANoA).
In a riverine town, where the population is exposed to methylmercury by fish consumption, both
prevalence and levels of autoantibodies were lower: 18% with detectable ANoA and 10.7% with detectable
ANA. In a reference site with lower mercury exposures, both prevalence and levels of autoantibodies
were much lower: only 2.0% detectable ANoA, and only 7.1% with detectable ANA. In the gold mining
population, we also examined serum for AFA in those subjects with detectable ANoA (≥1:10). There was
no evidence for mercury induction of this autoantibody.
Conclusions: This is the first study to report immunologic changes, indicative of autoimmune dysfunction
in persons exposed to mercury, which may also reflect interactions with infectious disease and other
factors.
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Background
Mercury has been recognized as a significant environmen-
tal and public health problem for more than 40 years, pri-
marily for its effects on the developing nervous system, as
expressed in tragic episodes of human poisoning in Japan
and Iraq [1]. Awareness of the effects of mercury on the
immune system has increased in the last decade [2,3].
In rodent models exposure to inorganic and organic mer-
cury has a range of immunotoxic effects, functionally
associated with decreased cell-mediated immunity and
the induction of autoimmunity [4]. These effects vary with
strain [5-7]. Both inorganic and organic forms of mercury
are immunotoxic, although they differ quantitatively and
qualitatively in their effects on the immune system; meth-
ylmercury may require metabolism into inorganic species
to induce immunotoxic effects, such that the effects of
methylmercury are delayed and reduced in appearance
[6]. Ethylmercury (C2H5Hg+), the active compound in
thimerosal and other medical compounds, induces in a
dose-dependent pattern all the features of systemic
autoimmunity that have been described after exposure to
mercuric chloride (HgCl2) [8]. Mercury can enter the body
through inhalation, as elemental mercury (Hg0), through
dermal or eye contact, as ethylmercury, and by absorption
through the gastrointestinal track, primarily as methylm-
ercury (CH3Hg+) through ingestion of contaminated fish
[1]. Inhaled Hg0 vapor easily crosses the pulmonary alve-
olar membranes to enter the circulatory system, where it
is primarily bound to red blood cells, and is rapidly dis-
tributed to the central nervous system, and the kidneys
[9]. Mercury absorbed through skin contact is oxidized in
the liver to Hg2+ by glutathione [10]. After entering the
blood stream, mercury is distributed to all tissues, includ-
ing the brain, kidney, lungs, hair, nails, liver, fetus, milk,
etc [1,10].
In the literature, no cases of frank autoimmune disease
have been reported in persons exposed to mercury, occu-
pationally or environmentally [3]. A few studies have
examined relationships between mercury exposures and
adverse immunological reactions, particularly in connec-
tion with mercury amalgam, but these are controversial
[1]. At relatively high levels of occupational exposure,
changes in immunoglobulins have been reported, but not
consistently [3,11-13]. Nephropathy described in workers
with either acute or chronic exposures to Hg0 vapor may
involve deposition of autoantibodies to basement mem-
brane proteins in the glomerulus [3,14]. In a study of
chloralkali workers, circulating anti-laminin antibodies
were found in some workers as well as autoantibodies
against glomerular basement membrane and circulating
immune complexes, but no significant increases in anti-
nuclear autoantibodies (ANA) were found [12]. No stud-
ies of immune parameters have been conducted in the
large longitudinal studies of children exposed to methyl-
mercury via fish consumption in the Seychelles or in the
Faeroe Islands [1,15,16]. In a cross-sectional study of a
maritime population of children with exposure to poly-
chlorinated biphenyls and methylmercury via seafood
consumption, numbers of naïve T-cell subsets
(CD4+CD45RA), T-cell proliferation, and plasma IgM
were decreased, while IgG levels were increased, relative to
controls [17].
The goal of this study was to test the hypothesis that expo-
sures to methylmercury and/or inorganic mercury may
have effects on specific markers of mercury-induced
autoimmunity, that is, ANA and antinucleolar (ANoA)
autoantibodies, and in a subset of subjects anti-fibrillarin
(AFA) autoantibodies. ANoA autoantibodies, a marker
found in some human autoimmune diseases [18], have
been reported to be elevated by mercury in mice [19].
More recently, Pollard et al. have proposed that ANoA
antibodies targeting the nucleolar 34-KDa protein fibril-
larin may be specific biomarkers of mercury-induced
immunotoxicity [20,21]. Mercury-induced ANoA in mice
reacts with a conserved epitope of fibrillarin [20,21],
which is indistinguishable from the AFA response seen in
scleroderma. A recent case-control study reported that
severely affected scleroderma patients with AFA were
more likely to have higher levels of mercury in urine, as
compared either to less severely affected cases without
AFA, or controls, suggesting an etiologic role for mercury
in this autoimmune disease [22]. However, the sample
size was small and levels of mercury were low in all
subjects.
We were able to conduct this study in collaboration with
an ongoing epidemiological surveillance of mercury expo-
sures in Amazonian Brazil, where populations are
exposed to both inorganic and organic mercury associated
with gold mining activities [23,24]. In Amazonian Brazil,
as in many other regions of the world, elemental mercury
is used in liquid form for amalgamation of gold particles
in placer deposits [23,25]. The gold miners are directly
exposed to inorganic mercury and residents of down-
stream communities are exposed to methylmercury via
consumption of fish. Extensive work has been done on
many of these populations, documenting a range of expo-
sures among miners and fish consumers [24-26], many
well above the levels found in populations in North
America and Europe, and well in excess of the levels found
in the Seychelles and Faeroes cohorts [1], although lower
than those reported in Minamata [27].
In this study we analyzed autoantibodies and mercury
exposures in three populations from the state of Pará, Bra-
zil. These groups were exposed to different types of mer-
cury in different settings, with exposure to other riskEnvironmental Health: A Global Access Science Source 2004, 3:11 http://www.ehjournal.net/content/3/1/11
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factors not all of which were determined. Therefore, these
may contribute to the observed differences among com-
munities, in addition to mercury exposures. We report
here that exposures to mercury are associated with signif-
icant increases in the prevalence of elevated serum ANoA.
Methods
To test our hypothesis we examined three separate popu-
lations, selected from ongoing studies of mercury expo-
sures and health status being conducted by FUNASA
(Fundaçao Nacional de Saúde), under the leadership of
Dr Santos of the Evandro Chagas Institute. The communi-
ties in our study were chosen from this surveillance data-
base on the basis of differences in exposures to mercury
and other risk factors in Pará, Brazil. At Rio-Rato, a garimpo
or gold mine site, most of the population was directly
involved in gold extraction and refining, resulting in rela-
tively high but often episodic exposures to inorganic mer-
cury, similar to those described by us and others [25,26].
This site is in the lower Tapajós River watershed, an area
of high malaria transmission [28]. At Jacareacanga, a river-
ine community on the Tapajós River several hundred km
downstream from the region of active gold mining in
Pará, the inhabitants consume fish known to be contami-
nated with methylmercury [24,29,30]. There is little auto-
chthonous malaria in this town but many people have
histories of malaria because of contact with the nearby
region [31]. Finally, at the village of Tabatinga, located on
the lower Amazon River east of the Tapajós, the popula-
tion has no direct or indirect contact with gold mining,
and fish collected in this village have levels of methylmer-
cury [24] within the guidelines for safe consumption rec-
ommended by the WHO and the US FDA [1]. Tabatinga
has had no prevalent malaria over the past ten years,
according to data from FUNASA (personal communica-
tion JM Souza).
Study design
The overall design of the mercury surveillance studies con-
ducted by Dr Santos is a community based, cross sectional
survey of Brazilian populations in Amazonia, focused on
the states of Pará, Amazonas, Acre, and Rondônia, includ-
ing gold mining sites, riverine communities, and popula-
tions without exposure to mercury. The study design is
described in detail by Santos and colleagues [29,32]. In all
studies, a census was first conducted at each site to deter-
mine sampling strategy. Subjects were then contacted by
house-to-house survey and enrolled in proportion to the
population in terms of age and gender. Overall, between
80 and 90% of contacted persons consented to participate
at each site. Information was collected by interview,
administered in Portuguese by trained personnel, to pro-
vide information on demographics (age, gender, educa-
tional attainment), diet (with particular emphasis on
fish), birthplace, current/previous occupation (including
use of mercury), income, health status, reproductive his-
tory (women), drug and alcohol use, past/current malaria,
number of people per household, time residing at the site,
and medical history. A short clinical examination was
conducted, and samples of hair, blood, urine, and stool
were taken for laboratory analyses, including mercury lev-
els in hair and urine. Malaria was assessed by question-
naire to determine past history of malaria (self reported),
as well as by thick smears taken to determine prevalent
malaria. All smears were read by trained technicians. Data
on past malaria were stratified using Baird as reference
[33], in which he determined the minimum number (4)
of prior malaria infections associated with acquisition of
functional immunity (i.e., no disease and/or parasitemia
after biting). The study was approved by the institutional
review board of the IEC and FUNASA. The University of
Maryland Medical School and the Johns Hopkins Medical
Institutions Institutional Review Boards also approved the
analyses conducted in this study.
Mercury exposure
Subjects' exposure to mercury was determined in two
ways. First, information was gathered by questionnaire on
occupational history (contact with and use of mercury in
gold mining), and/or fish consumption (by weekly fre-
quency and predominant types of fish consumed). Sec-
ond, mercury concentrations were measured in biologic
compartments. For persons in Tabatinga and Jacareacanga
with chronic exposure via fish consumption, hair mercury
(µg Hg/g of hair) was used as the exposure biomarker as
recommended [1]. Hair samples were collected in 2 cm
lengths (from the scalp) and analyzed using standard
methods of atomic absorption spectrophotometry by cold
vapor technique in the laboratory of Dr Santos, which par-
ticipates in the international QA/QC program with the
Université de Quebec [34]. For persons with occupational
exposures to inorganic mercury, in Rio-Rato, urine mer-
cury was used as the biomarker (µg Hg/L of urine, no data
on creatinine was available). This is the standard method
utilized by Santos and others for assessing occupational
exposures to inorganic mercury and generally reflects rel-
atively recent exposures [1,35].
Immunologic outcomes
Blood samples were collected by venipuncture and sera
were separated on site by centrifuge, aliquoted and imme-
diately frozen on liquid nitrogen for transport by air to the
IEC in Belem (Pará). Aliquots of frozen serum were stored
at -80°C and then transferred on dry ice to Baltimore via
air transport accompanied by Dr Silbergeld. All analyses
were done under blinded conditions.
Detection of ANA/ANoA
The serum samples were stored at -80°C until analysis.
Each aliquot was thawed and 10 µL taken for analysis byEnvironmental Health: A Global Access Science Source 2004, 3:11 http://www.ehjournal.net/content/3/1/11
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indirect immunofluorescence (IIF) microscopy using
commercially available slides prepared from human epi-
thelial cells (HEp-2) as substrate (INOVA Diagnostics)
following the methods of Burek and Rose [36]. The slides
were stored in the dark at 4°C until they were analyzed by
a blinded reader (IAS or AG). Randomly selected slides
were re-checked by an experienced immunologist (CLB).
Detection of AFA
The antigen proteins were obtained from rat liver nuclei
[20], and the proteins were separated by 15% SDS-PAGE.
Preparations were first fractionated by SDS-PAGE and
subsequently transferred to nitrocellulose and immunob-
lotted. Briefly, nitrocellulose was blocked in PBS/0.1%
Tween-20/5% dry milk for 2 h at room temperature. Incu-
bation with primary antibody (serum samples) (1/50 in
blocking solution) was performed at room temperature
for 1 h, followed by 3 washing steps of 10 min each in
PBS/0.1% Tween-20. Secondary antibody (horseradish
peroxidase-conjugated goat anti-human IgG) (Caltag Lab,
CA) was used at a dilution of 1/2000 in blocking solution
for 1 h at room temperature followed by 3 washes of 10
min each in PBS/0.1% Tween-20. Bound antibody was
detected using chemiluminescence. The 34 KDa protein
was detected by molecular weight using serum of sclero-
derma (SC) patients as a positive standard. The SC serum
revealed one band at the expected molecular weight of 34
KDa.
Data analyses
The concentration of serum autoantibodies is expressed in
terms of the dilution factor at which fluorescence could
still be detected. Detection of autoantibodies at a serum
dilution of ≥1:40 is considered "positive" for most clinical
uses [37]. However, detectability at dilutions between
1:10 and 1:40 can also have health implications [37] and
may be relevant as biomarkers of mercury exposure. Since
we are studying the autoantibodies as biomarkers of
immunotoxicity rather than as indicators of disease, we
present our findings at both dilutions, ≥1:40 and ≥1:10.
Statistical analysis
Means for continuous variables (median for variables
with skewed distributions) and percents for categorical
variables were computed for the descriptive analysis in
our data. Chi Square test was used to compare categorical
variables and Student's t-test was used for continuous var-
iables. In Jacareacanga we stratified hair mercury levels
based on World Health Organization guidance (≤8 or ≥8
µg/g hair). In Tabatinga we stratified exposure by the
observed median level (5.57 µg/g) since most hair mer-
cury concentrations were below 8 µg/g. In Rio-Rato we
used urine mercury levels based on WHO guidance (≤5 or
≥5 µg/L). We used the mean age for each population to
stratify by age. Logistic regression modeling was used to
evaluate the effect of mercury exposures on prevalence of
ANA and ANoA (for 1:10 and 1:40 cutoffs), while control-
ling for age, sex, prevalent malaria, past history of malaria,
and occupation. All data were analyzed using the SAS
v.8.1 statistical package.
Results
Because of substantial differences among the populations
and sites, we present the results for each site separately.
Tabatinga
Tabatinga is a typical riverine community in the lower
Amazon. The community sample consisted of 98 adults,
with 73% females, and a mean age of 44 years, (Table 1).
This community has no occupational exposures to inor-
ganic mercury, and the fish consumed have relatively low
methylmercury contamination. The distribution of hair
mercury is shown in Figure 1A; the majority of the persons
had hair mercury levels below 8 µg/g. The median hair
mercury concentration of 5.57 µg/g is higher than that
reported in European and North America populations,
which may reflect the very high frequency of fish con-
sumption rather than excessive fish contamination [38].
No present malaria cases were found, and only 10%
reported any past malaria (Table 2). Otherwise, the popu-
lation was in good health.
Table 1: Demographic characterization of the 3 populations
Current Occupation (%) Prev. Occupation
Populations N Age [Mean] Sex (%) F/M Gold Mine Fisherman Others Students Gold Miner (%)
Tabatinga-adults 98 44 73/27 0 1.1 98.9 0 0
Jacareacanga 140 25 54/46 0 2.2 72.4 25.4 9.4
Rio-Rato 98 30 35/65 54 0 46 0 N/A
N/A = data not available from original survey.Environmental Health: A Global Access Science Source 2004, 3:11 http://www.ehjournal.net/content/3/1/11
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Distribution of mercury levels Figure 1
Distribution of mercury levels Population distributions are shown for (A) Tabatinga and (B) Jacareacanga in µg Hg/g hair 
and (C) Rio-Rato in µg Hg/L urine.Environmental Health: A Global Access Science Source 2004, 3:11 http://www.ehjournal.net/content/3/1/11
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The prevalence of detectable ANA and ANoA in the Tabat-
inga samples was very low (Table 3; Figure 2). Most meas-
urements (90%) were not detectable even at the lowest
(1:10) dilution. These data are similar to those recently
reported for a referent population in Sao Paulo [39]. In
the few subjects with ANA or ANoA detectable at ≥1:10,
there was no relationship between ANA or ANoA for any
of the variables studied.
Jacareacanga
Jacareacanga is a riverine settlement of approximately 500
persons, located on the mid-Tapajós River. The 140 sub-
jects consisted of 54% women and had a mean age of 25
years (Table 1). Fish are the primary protein source and
piscivorous species sold at local markets have reported to
have elevated concentrations of methylmercury [29,30].
No persons reported current employment in gold mining
or refining, but some persons reported a history of such
activities. The distribution of hair mercury is shown in Fig-
ure 1B. Median hair mercury levels were 8 µg/g (Table 2),
substantially higher than that found in unexposed popu-
lations [1]. Fish consumption was the major predictor of
hair mercury; previous occupation as a gold miner was
also related to higher hair mercury concentrations. No
subjects were positive for malaria by blood smear at the
time of survey (Table 2). However, a majority reported a
history of past malaria (Table 2). Among these subjects,
50% reported 2 or fewer infections, while the maximum
number of past infections reported was 6.
As shown in Table 3, nearly 11% of the population had
detectable ANA ≥1:10, and nearly 20% had detectable
ANoA ≥1:10. In those subjects where ANA was detectable,
most (96.4%) presented at low concentrations, while
13% had ANoA detectable at 1:40 (Figure 2). No subjects
were positive for both autoantibodies. A significantly
higher percentage of subjects with detectable ANoA
(33%) had hair mercury levels greater than the median
value of 8 µg/g. In the logistical model only mercury, from
all the variables studied, was significantly correlated with
the presence of ANoA (≥1:10) (Table 4). Individuals with
higher hair mercury levels, who reported any past malaria,
were more likely to have detectable concentrations of
ANoA (40%) as compared to those with low mercury
levels. In persons reporting fewer than 4 past malaria
infections, hair mercury was positively correlated with the
presence of detectable ANA (≥1:10;  ≥1:40) and ANoA
(≥1:10) (Table 5). In persons with low hair mercury, there
was a positive correlation of number of past malaria infec-
tion with detectable ANA at either ≥1:10 or ≥1:40.
Rio-Rato
Rio-Rato is a gold mining community, where a small set-
tlement has grown up around a still active mining site in
Table 2: Malaria and Hg data from the 3 populations Malaria status (prevalent and reported past infections) and mercury exposures in 
the three populations.
Malaria Hg (median) Hg
Populations Prevalent (%) History (%) Urine (microgram/L) Hair (microgram/g) range values
Tabatinga-adults N = 98 0 10.1 ND 6.4 1.19–16.96
Jacareacanga N = 140 0 69.6 ND 8 0.29–58.47
Rio-Rato N = 98 93.9 N/A 4 ND 0.01–81.37
N/A = data not available from original survey.
ND = analysis not completed in original survey.
Table 3: Percentages of detectable ANA and ANoA in serum from the 3 populations
ANA (%) ANoA (%) ANA + ANoA (%)
Populations <det ≥1:10 ≥1:40 <det ≥1:10 ≥1:40 <det ≥1:10 ≥1:40
Tabatinga-adults N = 98 92.9 7.1 2.0 97.9 2.1 0 100 0 0
Jacareacanga N = 140 89.3 10.7 3.6 82.0 18.0 13.0 100 0 0
Rio-Rato N = 98 45.9 54.1 51.0 59.2 40.8 36.7 89.0 11.0 10.0
<det = below detection level at lowest dilution.
ANA ≥1:10 or ANoA ≥1:10 percentages include ANA 1 1:40 or ANoA ≥1:40 percentages.Environmental Health: A Global Access Science Source 2004, 3:11 http://www.ehjournal.net/content/3/1/11
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Detectable levels of serum autoantibodies Figure 2
Detectable levels of serum autoantibodies Population distributions of (A, C, E) ANA and (B, D, F) ANoA are shown for 
(A&B) Rio-Rato, (C&D) Jacareacanga and (E&F) Tabatinga, at varying serum dilutions.Environmental Health: A Global Access Science Source 2004, 3:11 http://www.ehjournal.net/content/3/1/11
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the mid-Tapajós watershed. Approximately 2/3 of the
population was male with a mean age of 30 years (Table
1). Educational and socioeconomic variables were low.
Urine mercury levels (4 µg/L) were lower than those
found in other mining populations in Amazonia
[25,26,40] (Figure 1C). Only 6 had levels ≥25 µg/L, the
median value found by us in another gold mine popula-
tion [40]. This may have been due to the timing of our
visit, during the dry season, when gold amalgamation
activities were reduced. A high degree of variability in
urine mercury levels among gold miners has been
reported by others [26,41]. Because of this, we used expo-
sure history to characterize mercury exposures in this
population.
This region has a high rate of malaria transmission
[28,31]. Over 90% of the Rio-Rato population had
prevalent malaria, detected by thick film slide at the time
of the survey (Table 2). No data on past malaria episodes
were collected. Over half of the population had ANA
detectable at ≥1:10, and nearly half had ANoA detectable
at ≥1:10 (Table 3; Figure 2). At or above 1:40, the Rio-Rato
population still presented with a high prevalence of ele-
vated ANA (51%) and ANoA (36.7%) (Table 3; Figure 2).
In 10% of the population, levels of both autoantibodies
were detectable at 1:40. About a quarter had concentra-
tions up to a dilution 1:160 and some persons in this sam-
ple had very high concentrations of autoantibodies,
detectable up to a dilution of 1:320. The likelihood of
ANoA detectable at 1:40 was significantly higher in those
individuals with a longer history of work in gold mining
(≥7 years compared to <4 years).
The presence of autoantibodies against the 34 KDa pro-
tein fibrillarin was determined by immunoblotting in
those serum samples from Rio-Rato with ANoA detectable
≥1:10. Of 40 subjects, 3 had serum with detectable AFA, as
shown in Figure 3.
Discussion
In this paper we report the first data on specific biomark-
ers of autoimmune dysfunction in persons exposed to
inorganic mercury or methylmercury. One earlier study
reported elevations in anti-laminin autoantibodies in
workers exposed to mercury [12]; however, no correlation
with mercury exposure was observed. While our data are
limited by sample size, and are likely influenced by other
variables in addition to mercury, the results are consistent
Table 4: Jacareacanga-odds ratio between risk factors and prevalence of ANoA ≥1:10 Logistical model for odds of detectable ANoA 
(≥1:10) and mercury exposure, gender, age, occupation, and malaria history, p < 0.05*.
Variable Odds ratio 95% Confidence interval p-value
Hg 3.27 1.28 – 8.37 0.014*
Gender 1.16 0.44 – 3.02 0.769
Age 0.93 0.36 – 2.39 0.871
Past-malaria 1.28 0.43 – 3.83 0.663
N past-malaria infections 1.18 0.39 – 3.55 0.772
Other occupations: gold miner 0.74 0.14 – 3.75 0.711
Table 5: Serum ANA and ANoA (Jacareacanga) stratified for mercury and past malaria infections P values obtained comparing Hg <8 
with >8 µg/g hair (* p < 0.05) and number of malaria infections <4 with ≥4 (§p < 0.05).
# malaria infections <4 (%) # malaria infections ≥4 (%)
Hg >8:
ANA 1:10 3.61 17.65 §
ANA 1:40 0 11.76 §
ANoA 1:10 12.05 17.65
ANoA 1:40 8.43 17.65
Hg ≥8:
ANA 1:10 14.81 * 10.00
ANA 1:40 11.11 * 0
ANoA 1:10 33.33 * 30.00
ANoA 1:40 22.22 20.00Environmental Health: A Global Access Science Source 2004, 3:11 http://www.ehjournal.net/content/3/1/11
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with the experimental literature indicating that mercury
can alter immune function and increase circulating levels
of autoantibodies, including ANA and ANoA [5,6,42].
There was an overall qualitative correlation between mer-
cury exposures and levels of ANA or ANoA, both by study
site and within study sites. Our ability to compare these
populations more directly was limited by differences in
the original study design with respect to mercury exposure
assessment (hair at Jacareacanga and Tabatinga, urine at
Rio-Rato). Persons from Tabatinga, with the lowest range
of mercury exposures, had lower prevalence of detectable
ANA or ANoA, and in those few persons with detectable
autoantibodies, the concentrations were low. Nonethe-
less, Tabatinga subjects had significantly elevated mercury
levels, as compared to North America populations [1,38],
which is probably attributable to their very high intake of
locally caught fish, such that even though these fish had
methylmercury levels below the US FDA or WHO guid-
ance, these consumption rates resulted in elevated body
burdens, as compared to North Americans eating fish
much less frequently [43]. Persons from Jacareacanga
were exposed to methylmercury from fish consumption.
The median hair mercury levels in Tabatinga and Jacarea-
canga are relatively close, but the distribution of hair mer-
cury in Jacareacanga shows that there are many persons
with exposures well above those obtained in Tabatinga. In
Jacareacanga subjects, higher prevalence of detectable
ANoA was observed, mostly at low concentrations (1:10
or 1:40), but several had levels measurable in dilutions as
high as 1:160. In Rio-Rato persons were highly exposed to
inorganic mercury from gold mining activities, as well as
methylmercury via fish consumption. Detectable levels of
ANA and/or ANoA were prevalent and detectable at high
concentrations (1:320).
It is possible that exposure to inorganic mercury may be
more "autoimmunogenic" than exposure to methylmer-
cury, as shown in mice models [6]. In contrast to studies
in mice [20,21], we found little evidence that AFA, levels
are specifically affected by mercury. This may indicate a
difference between humans and mice. However, as shown
in Figure 3, there appear to be many unidentified nuclear
antigens observed in serum samples from this population,
which were not observed in either the SC serum, or in
studies of US control subjects (data not shown). It would
be very pertinent to analyze sera from all these three pop-
ulations, using a range of other nuclear antigens known to
be targeted in autoimmune diseases [19,37].
We examined the serum ANA and ANoA results at both
1:10 and 1:40 dilutions. The results in Jacareacanga and
Rio-Rato subjects are clearly different from studies of
healthy individuals in the US and Brazil [39]. Interpreta-
tion must be cautious. Tan et al. [37] showed that many
"healthy individuals" (31.7%) show detectable ANA at
dilutions <1:40. This suggests that such a cutoff point for
serum dilution may have relatively little diagnostic value.
However, the purpose of this study was not to detect per-
sons with latent autoimmune disease, but rather to use
these antibody measurements as biomarkers to test the
hypothesis that mercury exposures might induce autoim-
mune dysfunction. A recent publication on the prevalence
of ANA in serum of normal blood donors in Brazil found
no age-related differences in prevalence of detectable ANA
among adults, and that very few subjects had detectable
ANA at dilutions >1:40 [39]. None of the subjects in these
populations were reported to have autoimmune disease
or overt clinical disease of any type, except malaria, but
only routine clinical assessments were done.
In Rio-Rato and Jacareacanga subjects, other risk factors
were related to elevations in ANoA and ANA. In Rio-Rato,
time spent at the site and in gold mining was positively
correlated with likelihood of elevated ANoA. This varia-
ble, time spent at the site, may represent length of expo-
sure to both mercury and malaria infection. In
Jacareacanga, there was a positive relationship between
malaria (any past reported cases) and likelihood of
elevated ANoA. We examined these potential biological
interactions among mercury, malaria, and autoimmune
biomarkers further, because of studies demonstrating that
repeated malaria infections are associated with increased
AFA in Rio-Rato serum samples Figure 3
AFA in Rio-Rato serum samples Photograph of denatur-
ing gel electrophoresis of 3 AFA positive samples from 41 
ANoA positive serum samples previously determined by IIF. 
Fibrillarin = 34 Kda protein.Environmental Health: A Global Access Science Source 2004, 3:11 http://www.ehjournal.net/content/3/1/11
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levels of autoantibodies, including ANA, presumably due
to cytotoxic damage and exposure of intracellular epitopes
[44,45]. Other studies have shown that autoantibodies
are produced in mice infected with malaria, which react
with several nuclear antigens, namely RNA, soluble
nuclear material and DNA [46]. Our data indicate that in
persons with lower mercury exposures (less than the
median of 8 µg/g hair), increasing number of past malaria
infections (≥4) were associated with increased likelihood
of ANA, but not ANoA. In persons with higher mercury
exposure, increased malaria exposure did not further
increase ANA. We do not, at present, have an explanation
for these observations, except to speculate that higher
mercury exposures may induce a strong autoimmune dys-
function, such that additional effects of malaria are not
significant.
It is difficult to draw any firm conclusions from these
analyses, since the malaria data in Jacareacanga were
based upon unconfirmed self-reports. We could not test
this hypothesis in the Rio-Rato group, since almost all
subjects had prevalent malaria and extensive histories of
past infection.
We have reported a suggested correlation between mer-
cury exposures and number of past malaria infections
among gold miners in another gold mine settlement, in
Brazil, at Piranha [40]. We have also reported that expo-
sure of mice to low levels of mercury both decreases host
resistance to murine malaria (Plasmodium yoelii) and
impairs acquisition of immunity to murine malaria in the
Nussenzweig model [47]. Mercury may reset immuno-
logic responses to malaria, to increase expression of
autoantibodies through its documented effects to up reg-
ulate Th2 mediated immune responses [48,49].
Finally, we may speculate as to why we have been able to
observe associations between mercury exposures and
these biomarkers of autoimmune dysfunction in these
populations, while most clinical or epidemiological stud-
ies of mercury and immunotoxicity have been negative or
only weakly positive [11-13]. In these other studies, the
cohorts were relatively small (between 44–70), and they
were exposed only to elemental or inorganic mercury
through working in mercury or chloralkali plants [11,13].
No reports of exposure to other risk factors, such as infec-
tious diseases, were reported. In our study, some of the
exposures were chronic in nature and included exposures
to methylmercury (certainly for fish consumption in
Amazonian populations, where fish form the major por-
tion of the protein consumed) [30,50]. In contrast, the
gold miners were likely to have relatively variable expo-
sures to inorganic mercury, with episodes of very high
inhalation exposure [25,26,41]. The role of genotype may
also be important. In rodents, genotype clearly plays an
important role in both modulating the immune response
to inorganic mercury as well as toxicokinetics [5-7,51]. In
susceptible mice, induction of genetically restrictive ANoA
by mercury are linked to mouse MHC (H-2) haplotype s
and q [7], while most other haplotypes confer relative
resistance [52]. Non-MHC genes decide the strength of
ANoA response in susceptible mice exposed to mercury
[6,7]. In addition, mercury toxicokinetics differ among
inbred mouse strains. As Nielson and Hultman [52] dem-
onstrated, there is a correlation between mercury toxicok-
inetics and AFA production in mice. In this study, the
populations in these communities represent a wide range
of ethnicities, including Europeans, Africans, and indige-
nous groups of Amazonia. Their immunogenetics may
include persons with increased susceptibility to mercury-
induced autoimmune dysfunction.
Conclusions
Our study is the first to report a correlation between
biomarkers (ANA and ANoA) and mercury exposure in
humans. In addition, co-exposures to mercury and infec-
tious diseases, including malaria, may set the stage for
eliciting discernible alterations in immune function.
Whether such co-exposures increase the risks of autoim-
mune disease will require further studies, which are
underway.
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